DAVID MOHR: Open Payments
NPI 1386687200 · BOGALUSA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 13 payments from 8 companies in 2025. Trend: 2023 $270 · 2024 $241 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $41 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| UCB, Inc. | 1 | $17 |
| Indivior Inc. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $14 |
Products named: Cologuard Collection Kit, Ozempic, The Cologuard Plus Collection Kit, PIFELTRO, Briviact, JARDIANCE, SUBLOCADE, Epclusa.
Industry payments across LA — which companies pay providers there.
